Advertisement

Topics

Companies Related to "Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study" [Most Relevant Company Matches] - Page: 2 RSS

22:21 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study" found in our extensive corporate database of over 50,000 company records.

Showing "Antigonadotropin Leuprolide Alzheimer Disease Drug INvestigation ALADDIN Study" Companies 26–50 of 6,100+

Relevant

ACADIA Pharmaceuticals Inc.

ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA is currently developing a portfolio consisting of four product candidates including pimavanserin, which is being developed for three separate neurological and psychiatric indi...


Privia

A clinical trial is a research study. Research studies are used to decide how treatments work and how safe they are. While in a study, a person may receive either an investigational drug, a marketed drug, a placebo, or a combination of these. An investigational drug is one that is nor approved by the Food and Drug Administration, a marketed drug is FDA approved and a placebo is like a "sugar pill"...

Proximagen Neuroscience plc

Proximagen Neuroscience plc is a publicly traded neuroscience research company focused on drug development for neurodegenerative disorders, including Parkinson's disease and Alzheimer's disease. Proximagen is building a compound pipeline to address the significant unmet medical needs of patients with neurodegenerative disease through its own discovery programme for novel, low risk therapeutic can...


Beta Amyloid Org

Beta Amyloid.org keeps up details of Alzheimer Research Labs, Alzheimer Research conferences around the world. Amyloid peptides being one of the major culprit of the Alzheimer Disease so our goal is to provide anything and everything to the researchers at one website. Beta Amyloid.org access is totally free; however, we don’t endorse any scientific information. Our team of scientists, editors an...

Alzheimer’s Greater Los Angeles

Alzheimer’s Greater Los Angeles (formerly known as Alzheimer’s Association, California Southland Chapter) provides programs and services free of charge to individuals with Alzheimer’s and related dementias, their families, caregivers and the community. Low cost training and education are also offered for professionals. Alzheimer’s Great...

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals, Inc. is a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases. Neuraltus has three clinical-stage programs in its development pipeline, including potential treatments for Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's...

Brain Injury Research Institute

The Brain Injury Research Institute is a center for the study of traumatic brain injuries and prevention, which is affiliated with the Blanchette Rockefeller Neuroscience Institute at West Virginia University. The purpose of the Institute is to study the short and long-term impact of brain injuries in order to better understand the impact of concussions, the development of chronic traumatic enceph...

New England Compounding Center

“New England Compounding Center (NECC) is working closely with the Massachusetts Board of Pharmacy, the Centers for Disease Control and the U.S. Food and Drug Administration on their investigation into the cause of infection in patients who received injections of methylprednisolone acetate. As part of this process, NECC has initiated a series of recalls ...

EXPERT BIOMED

Expert BioMed, Inc. is a privately-held biotechnology R&D company. The company focus is the development of prevention, diagnostic and therapy strategies to combat the Alzheimer's disease. In the Expert BioMed, Alzheimer cell and animal models and a set of monoclonal and polyclonal antibodies directed to new Alzheimer marker have been developed. The new diagnostic test for early cancer detection is...

Alzheimer's Disease International

SOURCE Alzheimer's Disease International

AFFiRiS AG

On the basis of the company's own patents, AFFiRiS develops tailor-made peptide vaccines against Alzheimer's disease, atherosclerosis, Parkinson's disease hypertension and four other conditions with an urgent medical requirement and attractive market volumes. Alzheimer's is currently the most advanced project, with two potential products having just completed the phase I clinical studies. In O...

Kinexis Inc

Kinexis, Inc. is a life science R&D company creating pharmaceutical and biopharmaceutical product opportunities based on promising early-stage inventions from academic institutions. Predictive animal models of human disease are employed to interrogate product concepts and validate product opportunities. Kinexis’ ultimate objective is to create a renewable pipeline of pre-clinical drug developme...

Alzheimer’s Orange County

Alzheimer’s Orange County provides programs and services, free of charge, to Orange County residents with Alzheimer’s and related dementia disorders, their families, caregivers, and the community. Alzheimer’s Orange County began as an independent 501c3 nonprofit in 1982, became a chapter of the national Alzheimer’s Association in 1984, and in ...

vTv Therapeutics, Inc.

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv Therapeutics has a pipeline of clinical drug candidates for the treatment of Alzheimer’s disease, diabetes, inflammatory disorders and the pre...

Karuna Pharmaceuticals, Inc.

Karuna is a clinical-stage drug development company targeting muscarinic cholinergic receptors for the treatment of psychosis and cognitive impairment across central nervous system (CNS) disorders, including schizophrenia and Alzheimer’s disease, as well as pain. Karuna’s lead product candidate, KarXT (Karuna-Xanomeline-Trospium), is being evalua...

TREVENTIS Corporation

TREVENTIS is headquartered in Southeastern Pennsylvania and has research operations in Halifax, Nova Scotia, Canada. The company is focused on the discovery and early stage development of disease- modifying small molecule drugs for Alzheimer’s and other protein misfolding diseases such as Parkinson’s and Huntington’s diseases. In addition to its ...

vTv Therapeutics LLC

vTv Therapeutics LLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and type 2 diabetes as well as treatment of in...

AmberGen, Inc.

AmberGen, Inc. is a development-stage Proteomics Company based in Waltham, Massachusetts. Dr. Kenneth Rothschild founded the company to develop tools for drug discovery and diagnostic assays based on in-vitro protein expression, photo cleavable linkers and novel labeling techniques. Several products are under development from this platform technology. The Molecular Therapeutics Division in Waltham...

The Genetics Company, Inc

The Genetics Company was founded in Zurich (Switzerland) in May 1998, as a joint spin-off between the University of Zurich and the Swiss Institute for Experimental Cancer Research (ISREC). In December 2002, the Company acquired key assets from CallistoGen AG in Berlin, Germany, substantially strengthening its in-house chemistry capabilities and expanding its product pipeline. This transaction was ...

California Neuroscience Research Medical Group, Inc.

California Neuroscience Research (CNR), is located at 4835 Van Nuys Blvd. in the Sherman Oaks Medical Center in Sherman Oaks, California. We perform clinical trial protocols of investigational medications or currently approved medications. These studies, funded primarily by major pharmaceutical sponsors, involve no costs to patients for study-related services. All study protocols are first appro...

vTv Therapeutics Inc.

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and type 2 diabetes as well as treatment of i...

KeyNeurotek AG

KeyNeurotek AG was founded in 2000 in Magdeburg, one of the leading European Centers of Neuroscience. Focused to the development of drugs for the treatment of acute and chronic neurodegenerative disorders of the Central Nervous System (e.g. stroke and Alzheimer disease), the company merges superior expertise in neurobiology, preclinical and clinical drug development, medicinal chemistry and in sil...

Neurome, Inc

Neurome, Inc. is a discovery stage biotechnology company that seeks therapeutic solutions to human neurodegenerative diseases. The company focuses its efforts on Alzheimer's disease, Parkinson's disease, Huntington's disease, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) - usually fatal neurodegenerative disorders that are currently untreatable and share characteristics which mak...

Neuronascent, Inc

Neuronascent began operations in a fully functional cell culture facility in Maryland. Neuronascent is in the process of developing small-molecule therapeutics for Alzheimer’s disease and depression as the main indications for its “neurogenesis” program. An orally-active, neurogenic agent could promote the formation of new neurons in key areas of the brain, replace damaged neurons, and reduc...

Amorfix Life Sciences Ltd.

The Aggregated Misfolded Protein diseases include Transmissible Spongiform Encephalopathies (TSE), such as Bovine Spongiform Encephalopathy (BSE) and the human form variant Creutzfeldt-Jakob Disease (vCJD), as well as degenerative diseases such as Alzheimer's Disease (AD), Amyotrophic Lateral Sclerosis (ALS) and Parkinson's Disease (PD).


More From BioPortfolio on "Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks